New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes

@article{Saltiel2001NewPI,
  title={New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes},
  author={Alan R. Saltiel},
  journal={Cell},
  year={2001},
  volume={104},
  pages={517-529}
}
  • A. Saltiel
  • Published 23 February 2001
  • Medicine, Biology
  • Cell
I thank Drs. Gerald Shulman, Wick Johnson, and Jeffrey Flier for reading of the manuscript, and Jeffrey Pessin and members of my laboratory for valuable discussions. I apologize for those papers that have not been cited due to space limitations, and for the many important areas of diabetes research that were not discussed. 
IRS2 takes center stage in the development of type 2 diabetes.
  • M. Brady
  • Biology, Medicine
  • The Journal of clinical investigation
  • 2004
TLDR
The recent identification of insulin receptor substrate 2 (IRS2) as a central player in the pathophysiology of many of these processes suggests a potentially unifying molecular link underlying the initiation and progression of type 2 diabetes. Expand
You are what you secrete
TLDR
Two new reports point to the adipocyte-secreted protein, adiponectin, as a new molecular target for treatment of type 2 diabetes, dyslipidemia and coagulation disorders. Expand
Discovering orphans' sweet secret: NR4A receptors and hepatic glucose production.
TLDR
A study by Pei et al. (2006b) identifies NR4A orphan nuclear receptors as a novel branch of cAMP-dependent regulators of hepatic glucose production under healthy and diabetic conditions. Expand
Skeletal Muscle Mitochondrial Function/Dysfunction and Type 2 Diabetes
© 2012 Gonzalez-Franquesa et al., licensee InTech. This is an open access chapter distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),Expand
Perspectives in Diabetes A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes , Metabolic Syndrome X , and Cushing ’ s Syndrome
Metabolic syndrome X and type 2 diabetes share many metabolic and morphological similarities with Cushing’s syndrome, a rare disorder caused by systemic glucocorticoid excess. Pathologies frequentlyExpand
Diabetic nephropathy in type 2 diabetes prevention and patient management.
  • G. Wolf, E. Ritz
  • Medicine
  • Journal of the American Society of Nephrology : JASN
  • 2003
It is an irony of medical progress that the renal involvement in diabetes mellitus type 2 had been considered twenty years ago ([1][1]) as a benign condition for the kidney without causing renalExpand
Fat cell insulin resistance : an experimental study focusing on molecular mechanisms in type 2 diabetes
The aim of the present thesis was to further increase our understanding of mechanisms contributing to and maintaining cellular insulin resistance in type 2 diabetes (T2D). For this reason, the effeExpand
Progress in Metabonomics of Type 2 Diabetes Mellitus
TLDR
This review summarized the metabonomics study of type 2 diabetes mellitus in recent years and provided a theoretical basis for the study of pathogenesis and the effective prevention and treatment of T2DM. Expand
IRS 2 takes center stage in the development of type 2 diabetes
886 The Journal of Clinical Investigation http://www.jci.org Volume 114 Number 7 October 2004 sumably, despite high local concentrations of stimulators in the tumor microenvironment, such as VEGF.Expand
A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome.
TLDR
Studies demonstrating that aberrant ceramide accumulation contributes to the development of the deleterious clinical manifestations associated withabolic syndrome X and type 2 diabetes are reviewed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 218 REFERENCES
The role of TNFα and TNF receptors in obesity and insulin resistance
TLDR
The role of TNFα and TNF receptors in obesity and insulin resistance and the potential role of “cell reprograming” in this situation is still under investigation. Expand
Evolution of β-Cell Dysfunction in the Male Zucker Diabetic Fatty Rat
TLDR
It is suggested that changes in the normal pattern of gene expression contribute to the development of β-cell dysfunction, and genes that play a key role in regulating insulin secretion and, thus, may be potential targets for therapeutic intervention aimed at preserving or improving β- cell function are identified. Expand
Obesity and insulin resistance.
TLDR
Recent progress in understanding of the adipo-insulin axis is reviewed, areas of controversy or uncertainty are highlighted, and approaches to clarifying the unresolved issues are suggested. Expand
Syndromes Associated with Insulin Resistance and Acanthosis Nigricans
  • S. Taylor, E. Arioglu
  • Chemistry, Medicine
  • Journal of basic and clinical physiology and pharmacology
  • 1998
TLDR
This paper focuses on patients with insulin resistance due to mutations in the insulin receptor gene, which is generally associated with two physiologic defects: insulin deficiency and insulin resistance 121. Expand
Cellular mechanisms of insulin resistance.
  • G. Shulman
  • Biology, Medicine
  • The Journal of clinical investigation
  • 2000
TLDR
It is shown that commonly accepted models that attempt to explain the association of insulin resistance and obesity are incompatible with recent findings and an alternative model is proposed that appears to fit these and other available data. Expand
PPARγ and the Treatment of Insulin Resistance
TLDR
Findings indicate that there is still much to learn about the molecular biology and physiology of these interesting receptors, and that research in this area can lead to more effective and safer drugs to treat insulin resistance and associated syndromes. Expand
Searching for Type 2 Diabetes Genes in the Post-genome Era
TLDR
Based on the results of several genome scans for genes encoding T2DM in various racial-ethnic groups, it appears that, as in other complex diseases, multiple genes are involved, each contributing a small amount to the overall risk. Expand
The role of TNFalpha and TNF receptors in obesity and insulin resistance.
TLDR
It is now clear that decreased signalling capacity of the insulin receptor is an important component of this disease and the potential mechanisms underlying this deficiency are reviewed. Expand
Disruption of IRS-2 causes type 2 diabetes in mice
TLDR
It is shown that disruption of IRS-2 impairs both peripheral insulin signalling and pancreatic β-cell function, indicating that dysfunction of IRS-2 may contribute to the pathophysiology of human type 2 diabetes. Expand
The hormone resistin links obesity to diabetes
TLDR
It is shown that adipocytes secrete a unique signalling molecule, which is named resistin (for resistance to insulin), which circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity. Expand
...
1
2
3
4
5
...